Clinical News

Clinical Status

<div class="articleContainer"><div class="articleWrapper"><div class="articleContent"><h1 class="text title">ESBA105: Phase IIa started</h1><div class="byline">WIR Staff</div><div class="date"></div></div></div></div>

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

ESBATech began an open-label, German Phase IIa trial to evaluate topical ESBA105 in 25 patients. ......

Inflammation

Ophthalmic

ESBA105: Phase IIa started

Featured Analysis

Articles by Category

Current Editions

Data Graphics

Discovery & Translation Analysis

Discovery & Translation

Hot Topics

BioCentury Podcasts 

Special Reports & Presentations

White Papers

Analysis

BCIQ

Company Profiles

Product Profiles

Target Profiles

Financial Dashboards

BCIQ Data Coverage

BCIQ Data

All Events

East-West Healthcare Reception

Bio€quity Europe

Grand Rounds — U.S.

Grand Rounds — Europe

The BioCentury-BayHelix China Healthcare Summit

China Healthcare Summit

3rd Biotech CEO & Investor Reception

At the East-West Summit, you will meet key players looking to globalize innovation from across Asia.